OPT 0.60% 83.5¢ opthea limited

Ann: Becoming a substantial holder, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 514 Posts.
    lightbulb Created with Sketch. 80

    In a one pager in the Weekend Australian titled "Best Investment Ideas for 2019" which listed 50 investment ideas, Opthea (18) in a subtitled section "Can biotechs cure an ailing portfolio?" was the first company mentioned as one to watch in 2019.

    2018 has largely been a year to forget for Australian biotech which included the failure of several companies (FTT,MSB,BNO and IMC) to meet primary end points in randomised, controlled phase II trials. Australian biotech is in need of a good news story. Fingers crossed, Opthea can deliver in 2019.

 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
83.5¢
Change
-0.005(0.60%)
Mkt cap ! $1.027B
Open High Low Value Volume
85.5¢ 85.5¢ 82.0¢ $11.20M 13.42M

Buyers (Bids)

No. Vol. Price($)
1 13018 83.0¢
 

Sellers (Offers)

Price($) Vol. No.
84.0¢ 3897 1
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.